UNSPSC 51282520: Cefadroxil hemihydrate

This classification denotes a cephalosporin antibiotic with the molecular formula 2C16H17N3O5S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J9CMF6461M, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, monohydrate, (6r-(6alpha,7beta(r*)))- but more generally known as cefadroxil hemihydrate, which bears US NIH Compound Identifier 47964. Most nations, for tariff and trade purposes, schedule cefadroxil hemihydrate under HS 29419000 and SITC 54139.

UNSPSC 51282520 Cefadroxil hemihydrate is a Commodity code for a specific antibiotic pharmaceutical product. Recent state and local procurement activity under this code shows minimal relevant sourcing; the two most recent tagged opportunities involve different pharmaceutical products entirely — Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets in one case, and Naloxone with drug deactivation systems in another — rather than cefadroxil hemihydrate itself. State and local health departments and county health agencies are the primary issuing bodies when pharmaceutical commodities are procured, typically through piggyback cooperative purchasing agreements or competitive invitation for bid processes with established pharmaceutical distributors as primary contractors.

The code shows little current demand signal under its nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic tablets, and Seminole County, Florida released an IFB in June 2026 for Naloxone and drug deactivation systems with a July 26, 2026 response deadline — but neither opportunity specifically solicits cefadroxil hemihydrate. The mismatch between the code's nominal scope and the actual products being bought suggests either tagging inconsistency or minimal current procurement activity for this particular antibiotic formulation at the state and local level. Firms supplying pharmaceutical commodities should verify demand through direct outreach to state pharmacy programs and county health purchasing offices rather than relying on this code alone.